Neoadjuvant and adjuvant treatment in high-risk prostate cancer.
Bandini M, Fossati N, Gandaglia G, Preisser F, Dell'Oglio P, Zaffuto E, Stabile A, Gallina A, Suardi N, Shariat SF, Montorsi F, Karakiewicz PI, Briganti A.
Bandini M, et al. Among authors: preisser f.
Expert Rev Clin Pharmacol. 2018 Apr;11(4):425-438. doi: 10.1080/17512433.2018.1429265. Epub 2018 Jan 25.
Expert Rev Clin Pharmacol. 2018.
PMID: 29355037
Review.